Amerigroup hires chief compliance officer
Georgia Dodds Foley to lead the office of business ethics and compliance programme
Dodds Foley joins Virginia Beach-based Amerigroup with more than two decades of experience focused on senior-level legal, compliance and ethics positions in the healthcare industry. Most recently, she was deputy compliance and ethics officer for CIGNA Corporation in Philadelphia, overseeing compliance for the organisation's domestic operations.
You may also like
Manufacturing
![Why CAPA keeps failing and what strong organisations do differently]()
Why CAPA keeps failing and what strong organisations do differently
This white paper examines why CAPA systems often close records without preventing recurrence, tracing breakdowns to investigation quality, risk reasoning, and organisational behaviour rather than procedural gaps. It outlines what differentiates compliant CAPA programmes from those that consistently reduce repeat findings and inspection risk
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part II)]()
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part II)
How a centralised qualification matrix reconciles vendor documentation, integrates risk-based verification and connects commissioning findings with deviation, CAPA and audit-ready evidence
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
![Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part I)]()
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part I)
Documentation Specialist Snehal Godse explains why unit-level FAT and SAT leave critical multivendor interfaces unverified and proposes a risk-based framework to qualify product transfers, control signals, interlocks, sensors and shared utilities
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Research grade to GMP: how peptide quality requirements change as development progresses]()
Research grade to GMP: how peptide quality requirements change as development progresses
This article presents a practical guide to matching peptide characterisation, impurity control, traceability and manufacturing oversight with rising regulatory expectations across preclinical and clinical development
